Role and Diagnostic Significance of Apolipoprotein D in Selected Neurodegenerative Disorders

Role and Diagnostic Significance of Apolipoprotein D in Selected Neurodegenerative Disorders

The World Health Organization in 2021 ranked Alzheimer’s disease and other dementias as the seventh leading cause of death globally. Neurodegenerative disorders are progressive, intractable, and often fatal diseases. Early diagnosis may allow patients to enjoy prolonged survival with attenuated symp...

Full description

Saved in:

Bibliographic Details
Main Authors:	Agata Kolanek, Roman Cemaga, Mateusz Maciejczyk
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Diagnostics
Subjects:	apolipoprotein D biomarker central nervous system multiple sclerosis Alzheimer’s disease Parkinson’s disease
Online Access:	https://www.mdpi.com/2075-4418/14/24/2814
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multi-functional role of apolipoprotein E in neurodegenerative diseases
by: Sadequl Islam, et al.
Published: (2025-01-01)

Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases
by: Simona Denaro, et al.
Published: (2025-02-01)

Research progress on the mechanisms of apolipoprotein E in Alzheimer’s disease
by: Jiayuan Li, et al.
Published: (2025-01-01)

Pharmacogenomics for neurodegenerative disorders - a focused review
by: S. Rehan Ahmad, et al.
Published: (2024-12-01)

Copper homeostasis and neurodegenerative diseases
by: Yuanyuan Wang, et al.
Published: (2025-11-01)

Association analyses of nutritional markers with Parkinson’s disease and Alzheimer’s disease
by: Dong-Juan Xu, et al.
Published: (2024-11-01)

Application of Nanobiosensor engineering in the diagnosis of neurodegenerative disorders
by: Thikra S. Dhahi, et al.
Published: (2024-12-01)

Epigenetic Mechanisms Underlying Sex Differences in Neurodegenerative Diseases
by: Andrea Stoccoro
Published: (2025-01-01)

Advancements in Targeting Ion Channels for the Treatment of Neurodegenerative Diseases
by: Yuxuan Li, et al.
Published: (2024-10-01)

Examining vaccination-related adverse events in frequent neurodegenerative diseases
by: Shabnam Sodagari, et al.
Published: (2025-02-01)

Role of Thyroid Hormone in Neurodegenerative Disorders of Older People
by: Arshag D. Mooradian, et al.
Published: (2025-01-01)

Neuroborreliosis mimicking demyelinating disease of the central nervous system: case reports
by: N. Giedraitienė, et al.
Published: (2018-09-01)

Apolipoprotein B gene expression and regulation in relation to Alzheimer’s disease pathophysiology
by: Gabriel Aumont-Rodrigue, et al.
Published: (2024-11-01)

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosisResearch in context
by: Dang Wei, et al.
Published: (2025-03-01)

Exosomes in multiple sclerosis and Alzheimer's disease – Adversary and ally
by: Norina Tang
Published: (2024-10-01)

Pathways to Alzheimer’s Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health
by: Alexandru Laslo, et al.
Published: (2024-10-01)

The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies
by: Muhammad Abu Talha Safdar Hashmi, et al.
Published: (2024-12-01)

Apolipoprotein E dysfunction in Alzheimer’s disease: a study on miRNA regulation, glial markers, and amyloid pathology
by: Printha Wijesinghe, et al.
Published: (2024-12-01)

Application of optical coherence tomography in neurodegenerative diseases: a focus on Parkinson’s, Alzheimer’s, and Schizophrenia in Bulgarian patients
by: Alina Y. Levi, et al.
Published: (2024-12-01)

Calcium Signalling in Neurological Disorders, with Insights from Miniature Fluorescence Microscopy
by: Dechuan Sun, et al.
Published: (2024-12-01)

Editorial: Oxytosis/ferroptosis: unraveling the mechanisms and its multifaceted role in neurodegenerative diseases
by: Nawab John Dar, et al.
Published: (2025-01-01)

Body and mind: how obesity triggers neuropsychiatric and neurodegenerative disorders
by: Claudio Pirozzi, et al.
Published: (2025-01-01)

Changes in serum neurofilament light chain protein levels in patients with neurodegenerative diseases: a Meta-analysis
by: FU Xudong, et al.
Published: (2024-04-01)

Genetic variability of incretin receptors affects the occurrence of neurodegenerative diseases and their characteristics
by: David Vogrinc, et al.
Published: (2024-10-01)

Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases
by: Qiuyan Ye, et al.
Published: (2024-11-01)

Genetic Insights Into the Role of Cathepsins in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis: Evidence From Mendelian Randomization Study
by: Yanhong Jiang, et al.
Published: (2025-01-01)

Unravelling the Evolution of Neurodegenerative Disease Mortality: Insights from 50 Years of Belgian Data
by: Janna Dinneweth, et al.
Published: (2024-11-01)

Anxiolytic, Antidepressant, and Anticholinesterase Effects of Essential Oil from <i>Myrcia sylvatica</i> (G.Mey.) DC
by: Antônio Quaresma da Silva Júnior, et al.
Published: (2025-01-01)

Exploring the Connection Between Nanomaterials and Neurodegenerative Disorders
by: Sitansu Sekhar Nanda, et al.
Published: (2024-11-01)

Recent Advances in Bacopa Monnieri Research: Neuroprotective Effects and Cognitive Decline Mitigation in Neurodegenerative Diseases with a Focus on Alzheimer’s and Parkinson’s Diseases
by: Mateusz Bychowski, et al.
Published: (2024-12-01)

Carvacrol Essential Oil as a Neuroprotective Agent: A Review of the Study Designs and Recent Advances
by: Fahad Khan Tareen, et al.
Published: (2024-12-01)

Impact of Mast Cell Activation on Neurodegeneration: A Potential Role for Gut–Brain Axis and <i>Helicobacter pylori</i> Infection
by: Marina Boziki, et al.
Published: (2024-12-01)

APOE ε4 and exercise interact in a sex‐specific manner to modulate dementia risk factors
by: Kate E. Foley, et al.
Published: (2022-01-01)

Longitudinal analysis of adiponectin to leptin and apolipoprotein B to A1 ratios as markers of future airflow obstruction and lung function decline
by: Seohyun Kim, et al.
Published: (2024-11-01)

Sleep quality among sample of Egyptian patients with Alzheimer’s disease: risk factors and role of genetic profiling for ACE, ACE 2 and APO E genotypes
by: Khaled Ahmed Elbeh, et al.
Published: (2025-01-01)

Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review
by: Ubaid Ansari, et al.
Published: (2024-12-01)

Hippocampal volumes in UK Biobank are associated with APOE only in older adults
by: Ariya Chaloemtoem, et al.
Published: (2024-10-01)

Concordance and test-retest consistency of sleep biomarker-based neurodegenerative disorder profiling
by: Daniel J. Levendowski, et al.
Published: (2024-12-01)

Deciphering the spectrum of astrocyte diversity: Insights into molecular, morphological, and functional dimensions in health and neurodegenerative diseases
by: Fumito Endo
Published: (2025-01-01)

Editorial: Extracellular vesicles: emerging roles in the aged and neurodegenerative brain
by: Foteini Vasilopoulou, et al.
Published: (2024-12-01)